HBW Advisory Services LLC Acquires Shares of 416 Amedisys, Inc. (NASDAQ:AMED)

HBW Advisory Services LLC acquired a new stake in Amedisys, Inc. (NASDAQ:AMED) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 416 shares of the health services provider’s stock, valued at approximately $38,000.

A number of other hedge funds have also modified their holdings of the stock. Polar Asset Management Partners Inc. bought a new stake in Amedisys during the third quarter worth about $28,953,000. SG Americas Securities LLC grew its position in Amedisys by 413.4% during the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider’s stock worth $18,985,000 after acquiring an additional 158,398 shares during the last quarter. Verition Fund Management LLC increased its holdings in Amedisys by 608.1% during the 3rd quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider’s stock valued at $11,077,000 after purchasing an additional 98,565 shares in the last quarter. Westchester Capital Management LLC raised its position in Amedisys by 9.5% in the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider’s stock valued at $107,976,000 after purchasing an additional 97,476 shares during the last quarter. Finally, Highbridge Capital Management LLC boosted its stake in Amedisys by 34.7% in the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after purchasing an additional 83,200 shares in the last quarter. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Stock Performance

Amedisys stock opened at $91.90 on Friday. The stock has a 50-day simple moving average of $89.49 and a 200 day simple moving average of $94.43. The stock has a market capitalization of $3.01 billion, a price-to-earnings ratio of 36.47, a P/E/G ratio of 1.84 and a beta of 0.72. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 12-month low of $82.15 and a 12-month high of $98.95.

Amedisys (NASDAQ:AMED) last announced its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.98 earnings per share. On average, research analysts anticipate that Amedisys, Inc. will post 4.45 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.